UBS Maintains Neutral on QuidelOrtho, Lowers Price Target to $17

Benzinga Newsdesk www.benzinga.com Negative 88.7%

Neg 88.7% Neu 0% Pos 0%

UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $30 to $17.

Comments

No comments yet. Be the first!